Medical Packaging Valuation
Is MEPA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MEPA?
Other financial metrics that can be useful for relative valuation.
What is MEPA's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | ج.م134.55m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.7x |
Enterprise Value/EBITDA | 9x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does MEPA's PE Ratio compare to its peers?
Company | PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.8x | ||
MEGM Middle East Glass Manufacturing CompanyE | 3.9x | n/a | ج.م785.4m |
DTPP Delta For Printing & PackagingE | 6.9x | n/a | ج.م111.4m |
UNIP Universal For Paper and Packaging Materials | 17.9x | n/a | ج.م395.8m |
ALUM Arab Aluminum Company (S.A.E) | 10.6x | n/a | ج.م222.5m |
MEPA Medical Packaging | 15.3x | n/a | ج.م134.6m |
Price-To-Earnings vs Peers: MEPA is expensive based on its Price-To-Earnings Ratio (15.3x) compared to the peer average (9.8x).
Price to Earnings Ratio vs Industry
How does MEPA's PE Ratio compare vs other companies in the Global Packaging Industry?
Price to Earnings Ratio vs Fair Ratio
What is MEPA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 15.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MEPA's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of MEPA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MEPA (EGP0.39) is trading below our estimate of fair value (EGP1.69)
Significantly Below Fair Value: MEPA is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.